FREE hit counter and Internet traffic statistics from
Partnerships & Opportunities


For further information
regarding partnership
opportunities at Ichor
contact May de las Alas.

Email May de las Alas

Ichor has established several ongoing research and development collaborations and licensing agreements to advance the development of electroporation-mediated DNA drug delivery. Ichor is collaborating with partners to provide its enabling TriGrid™ platform as a means for delivery of DNA drugs and vaccines in disease indications such as melanoma, malaria, hepatitis B virus (HBV) infection, human immunodeficiency virus (HIV) infection, influenza, and others.

We are open to exploring additional research and development partnerships that would utilize our expertise in DNA drug delivery to optimize the clinical results of new and existing DNA drugs or vaccines. We also seek partners with complementary resources and capabilities.

Aaron Diamond AIDS Research Center Aldevron Delphi Genetics
EpiVax, Inc. Genexine Institute for Immunology and Informatics - University of Rhode Island
INSERM The Johns Hopkins University Naval Medical Research Center (NMRC)
Profectus Biosciences, Inc. Scancell Company, Ltd The Scripps Research Institute
Tulane University - School of Public Health & Tropical Medicine United States Army Medical Research Intitute of Infectious Diseases (USAMRIID) Vaccibody
The Vaccine and Infectious Disease Organization (VIDO)